Newly diagnosed multiple myeloma - Globe Thesis

Keyword [Newly diagnosed multiple myeloma] Result: 41 - 60 \| Page: 3 of 4
41.	Prognostic Significance Of CD27 And CD56 On Newly Diagnosed Multiple Myeloma Treated With Bortezomib
42.	Retrospective Analysis On Clinical Data Of 375 Patients With Newly Diagnosed Multiple Myeloma
43.	The Prognostic Significance Of Lactate Dehydrogenase,Serum Ferritin And Combined Detection In Newly Diagnosed Multiple Myeloma
44.	The Efficacy And Safety Analysis Of Xintai Combined With Chemotherapy For Newly Diagnosed Multiple Myeloma And Literature Review
45.	Clinical Characteristics And Efficacy Analysis Of Newly Diagnosed Multiple Myeloma Patients Complicated With Light Chain Amyloidosis
46.	The Clinical Characteristics Of 145 Cases Of Newly Diagnosed Multiple Myeloma And The Clinical Analysis Of Bortezomib-based Chemotherapy
47.	The Significance Of Serum Free Light Chain Detection In Evaluating The Prognosis Of Newly Diagnosed Multiple Myeloma Patients
48.	Evaluating The Value And Budget Impact Analysis Of Daratumumab For The Treatment Of Patients With Transplant-ineligible Newly Diagnosed Multiple Myeloma
49.	Mutation, SNP and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients
50.	The Effect And The Mechanism Of DEPTOR On Angiogenesis In Multiple Myeloma
51.	Biomarkers To Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing And Validating Nomogram Prognostic Models
52.	Prognostic Value Of ¹⁸F-FDG PET/CT Imaging In Newly Diagnosed Multiple Myeloma And Construction Of A Novel Prognostic Model
53.	Pegylated Liposomal Doxorubicin Combined With Different Regimens For Patients With Newly Diagnosed Multiple Myeloma:a Retrospective Study Of Efficacy And Safety
54.	A Predictive Model Based On The Risk Factors Associated With Early Mortality In Patients With Newly Diagnosed Multiple Myeloma
55.	Analysis Of The Relationship Between Immunophenotypic Expression And Prognosis In Patients With Newly Diagnosed Multiple Myeloma
56.	Analysis Of Clinical Features And Prognoses Of 169 Patients With Newly Diagnosed Multiple Myeloma
57.	Preliminary Analysis On Clinical Features,treatment And Prognosis In Patients With Newly Diagnosed Multiple Myeloma
58.	Prognostic Significance Of The Lymphocyte-to-monocyte Ratio And Corrected Levels Of Serum Calcium In Patients With Newly Diagnosed Multiple Myeloma
59.	Comparative Study Of Domestic And Original Bortezomib In The First-Line Treatment Of Newly Diagnosed Multiple Myeloma
60.	Prognostic Value Of Different Risk Stratification In Newly Diagnosed Multiple Myeloma
<<First <Prev Next> Last>> Jump to